This study was performed to investigate the effects of goshajinkigan, a traditional Chinese herbal mixture, in conscious rats undergoing continuous cystometry.
INTRODUCTION
The urinary bladder is rich in afferent nerve fibers, which can be divided into two types: myelinated Aδ fibers and unmyelinated C-fibers. C-fibers can be activated by chemical irritants, such as acetic acid and heat, but they are currently considered to play no role in normal micturition (Andersson, 2003) . However, in some neurological diseases, such as multiple sclerosis or spinal cord lesions, the C-fibers may become sensitive to mechanical stimulation and take part in voiding reflexes. Clinically, capsaicin and resiniferatoxin (RTX), which desensitize C-fiber afferents via vanilloid receptor-1 (VR1) (Caterina et al., 1997) , have been reported to be effective in the treatment of bladder overactivity induced by different neurological diseases (Craft et al., 1995; Komiyama et al., 1999) .
Most drugs in current use for the treatment of incontinence are believed to act peripherally; they can be classified as drugs that affect sensory nerves and those that mainly reduce detrusor contractility. Antimuscarinic agents that reduce detrusor contractility are still the first line of therapy. However, side effects, such as dry mouth, remain the main reasons for poor patient compliance in clinical practice (Chapple et al., 2002) . Goshajinkigan is a traditional Chinese herbal mixture that contains ten ingredients (Table 1) , and has long been used in China and Japan to alleviate the subjective symptoms of diabetic neuropathy (Tawata et al., 1994) . Due to this clinical effect, we felt that this drug might be useful in improving bladder overactivity.
In the present study, we investigated the effects of goshajinkigan, a traditional Chinese herbal mixture, in conscious rats undergoing continuous cystometry. Systemic RTX pretreatment can block the bladder overactivity mediated by RTX-sensitive (C-fiber) nerves, such as that induced by intravesical administration of acetic acid. We also compared the effects of pretreatment with goshajinkigan and RTX, alone or in combination, on acetic acid-induced bladder overactivity in conscious rats.
MATERIALS AND METHODS

Animals
Female Sprague-Dawley rats from 8 to 12 weeks old were used in this study, which was conducted in accordance with the guidelines approved by the Animal Ethics Committee, Shinshu University School of Medicine. All the rats were group-housed in cages for at least one week before the experiment and were fed laboratory chow and water ad libitum. The temperature of the animal house was maintained at 23±1°C with a 12-h light/dark cycle (lights on at 09:00).
Goshajinkigan pretreatment
Four weeks before bladder catheter implantation, the animals were assigned at random to 4 groups, each of which consisted of 6 animals. Groups (1) and (3) received normal food, while groups (2) and (4) received special food containing goshajinkigan (0.09 g/kg/day) for 4 weeks. The herbal extract of goshajinkigan was kindly provided by Tsumura Co. (Tokyo, Japan). The extract was composed of 10 medicinal plants, as shown in Table 1 , extracted with hot water, filtered, and lyophilized. The dosage used in the experiments was the extracted weight. A dose of 7.5 g/day is used in humans. The animal food in the present study contained 1.08% extract of goshajinkigan, representing a dose approximately 10-fold higher than that used in humans based on previous reports (Tawata et al., 1994; Hu et al., 2003) . The animals took about 15 g/day of this special diet.
Bladder catheter implantation
Rats were anesthetized by i.m. injection of ketamine (75 mg/kg) and xylazine (15 mg/kg). The bladder was exposed through an abdominal midline incision and a small incision was made at the bladder dome. A polyethylene catheter (PE50; Nippon Becton Dickinson, Tokyo, Japan) was implanted into the bladder as described previously (Malmgren et al., 1987) . The free end of the catheter was tunneled subcutaneously and exteriorized at the back of the neck. All the rats were maintained individually in cages under a 12-h alternating light-dark cycle, with food and water available ad libitum.
RTX pretreatment
Two days after bladder catheter implantation. Animals in groups (3) and (4) received RTX (0.3 mg/kg, 0.75 mg/ml, s.c.) by subcutaneous injection, while those in groups (1) and (2) received vehicle alone.
Cystometric investigation
Cystometric investigation was performed without anesthesia 3 days after bladder catheter implantation. The bladder was connected via a T-tube to a pressure transducer (P23 DC; Statham, Oxnard, CA, USA) and a microinjection pump (Model 200;
Muromachi-Kikai, Tokyo, Japan). The conscious rats were placed without any restraint in a metabolic cage (Nalgen, 650-0100, Nalge Nunc, Rochester, NY), which also enabled measurement of micturition volume by means of a fluid collector connected to a force displacement transducer (Type 45196; NEC San-ei Instruments, Tokyo, Japan).
Saline maintained at room temperature was instilled into the bladder at a rate of 10 ml/h. analyzed. The following cystometric parameters were investigated: basal pressure, threshold pressure (bladder pressure immediately prior to micturition), micturition pressure, voiding interval, micturition volume, residual volume, and bladder capacity (Malmgren et al., 1987) . Six animals were used for intravesical administration of each drug.
Administration of drugs
Resiniferatoxin (Sigma, St. Louis, MO) was dissolved in absolute ethanol as a 1 mM stock solution and stored at -70°C. The stock solution was diluted to appropriate final concentrations in saline just before use. Acetic acid (Wako, Osaka, Japan) was diluted with saline and pH was adjusted to 4.0 (about 200 µl of 99% acetic acid per 1000 ml saline) using a pH/ion meter (F23, Horiba, Kyoto, Japan).
Statistical analysis
Results are given as means ± SD. Student's two-tailed t-test was used for comparison of baseline values between the control group, goshajinkigan-pretreated group, and RTX-pretreated group, and was also used for comparisons of paired samples before and after acetic acid administration. One-way factorial ANOVA followed by Scheffe's F-test was used for comparisons of body weight and drug effects between different animal groups, with p<0.05 accepted as significant.
RESULTS
Body weight of the rats
The rats weighed (1) 227±7.5 g, (2) 231±6.8 g, (3) 230±5.8 g, and (4) 225±6.3 g just before cystometic investigation. There were no significant differences in body weight among the groups.
Effects of goshajinkigan pretreatment
Four weeks of goshajinkigan pretreatment induced significant increases in threshold pressure (p<0.05), voiding interval (p<0.05), micturition volume (p<0.05), and bladder capacity (p<0.05, Table 2 ).
Effects of RTX pretreatment
Systemic RTX pretreatment induced a significant decrease in basal pressure, and significant increases in threshold pressure, voiding interval, micturition volume, and bladder capacity (p<0.001, Table 2 ).
Effects of intravesical acetic acid in vehicle-pretreated rats
Intravesical instillation of acetic acid (pH 4.0) induced statistically significant increases in basal pressure (p<0.05) and micturition pressure (p<0.05), and significant decreases in voiding interval (p<0.001), micturition volume (p<0.001), and bladder capacity (p<0.01) (Fig. 1, Table 2 ).
Effects of intravesical acetic acid in goshajinkigan-pretreated rats
In rats pretreated with goshajinkigan, intravesical instillation of acetic acid (pH 4.0) induced a statistically significant increase in basal pressure (p<0.05), and significant decreases in threshold pressure (p<0.05), voiding interval (0.05), micturition volume (p<0.05), and bladder capacity (p<0.05). There were significant differences in voiding interval (p<0.05) and micturition volume (p<0.05) between the normal food group and goshajinkigan-pretreated group (Fig. 2, Table 2 ).
Effects of intravesical acetic acid in RTX-pretreated rats
In rats pretreated with RTX (0.3 mg/kg), intravesical instillation of acetic acid (pH 4.0) induced significant decreases in threshold pressure (p<0.05). There were significant differences in basal pressure (p<0.05), micturition pressure (p<0.05), voiding interval (p<0.01), micturition volume (p<0.01), and bladder capacity (p<0.05) between the vehicle-pretreated group and RTX-pretreated group (Table 2) .
Effects of intravesical acetic acid in both goshajinkigan-and RTX-pretreated rats
In rats pretreated with both goshajinkigan and RTX, intravesical instillation of acetic acid (pH 4.0) did not induce any statistically significant changes in the voiding parameters (Table 2) .
DISCUSSION
In the present study, injection of RTX (0.3 mg/kg, s.c.) 24 h before cystometric investigation induced significant increases in threshold pressure, voiding interval, micturition volume, and bladder capacity as compared with the same parameters in the vehicle-pretreated controls. In humans, RTX-sensitive nerves are considered to play no role in micturition under normal conditions (Andersson, 2002) . However, in rats, this afferent nerve may play a role in the modulation of micturition (Zhang et al., 2003) .
Goshajinkigan has long been used in China and Japan, mainly to relieve the subjective symptoms of diabetic neuropathy (Tawata et al., 1994) . Due to this clinical effect, we felt that this drug might be useful to improve bladder overactivity with fewer of the side effects, such as dry mouth and constipation, associated with conventional therapeutic agents. However, the possible mechanisms of the effectiveness of this drug for overactive bladder were not confirmed sufficiently from the viewpoint of both basic and clinical studies. The present study using continuous cystometry in conscious animals indicated that 4-week administration of this drug significantly increased micturition volume, bladder capacity, and micturition interval. As the extract was administered orally, it was not easy to determine the site of action of this drug in the micturition cycle of the rats. To clarify one of the mechanisms of action, we focused on the RTX-sensitive neurons, which are considered to induce bladder overactivity (Craft et al., 1995; Komiyama et al., 1999) . However, further studies are needed to clarify the other mechanisms. In the present study, acetic acid was shown to induce bladder overactivity, but this overactivity did not appear in RTX-pretreated animals. This observation implied that this overactivity was mediated by RTX-sensitive afferent neurons in the bladder. Acetic acid caused bladder overactivity in both control and goshajinkigan-pretreated rats. However, there were significant differences in voiding interval and micturition volume between these two groups. Our results suggested that goshajinkigan pretreatment has a blocking effect on intravesical acetic acid-induced bladder overactivity, possibly via inhibition of bladder RTX-sensitive afferent nerves, but the effect was relatively mild as compared with that of RTX pretreatment.
The present study showed that goshajinkigan increased voiding interval, Naunnyn-Schmiedeberg's Arch. Pharmacol. 367: 473-479, 2003 . Table 1 Composition of Goshajinkigan.
LEGENDS TO TABLES AND FIGURES
Samples of 4.5 g of extract of goshajinkigan were composed of these plants.
Table 2
Effects of intravesical administration of acetic acid (pH 4.0) on cystometric parameters in vehicle-, RTX-, and goshajinkigan-pretreated rats. Table 1 Composition of Goshajinkigan. Samples of 4.5 g of extract of goshajinkigan were composed of these plants.
Plant name (g)
Rehmannia glutinosa 5
Achyranthes Root 3
Cornus officinalis 3
Dioscorea Rhizome 3
Plantago seed 3
Alisma orieentale 3
Porica cocos 3
Moutan Cortex 3
Cinnamomum Cassia 1
